{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:20:41Z","timestamp":1790418041746,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/jcp.0b013e3181db320f","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T08:28:32Z","timestamp":1273048112000},"page":"300-305","source":"Crossref","is-referenced-by-count":15,"title":["A Pooled MADRS\/IDS Cross-Correlation Analysis"],"prefix":"10.1097","volume":"30","author":[{"given":"Frederick W.","family":"Reimherr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Eudicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrie K.","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Van","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Pikalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit X.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archpsyc.64.3.305","article-title":"Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life.","volume":"64","author":"Williams","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"23","key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"5288","key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1126\/science.274.5288.740","article-title":"Evidence-based health policy-lessons from the Global Burden of Disease Study.","volume":"274","author":"Murray","year":"1996","journal-title":"Science"},{"issue":"9064","key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"issue":"8","key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression.","volume":"53","author":"Fava","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"1","key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice.","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"11","key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report.","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"2","key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1176\/ajp.2007.164.2.201","article-title":"STARD: what have we learned?","volume":"164","author":"Rush","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00004714-200302000-00013","article-title":"Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.","volume":"23","author":"Nierenberg","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4088\/JCP.v64n0407","article-title":"A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.","volume":"64","author":"Barbosa","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.jcp.0000246212.03530.fd","article-title":"A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.","volume":"26","author":"Patkar","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10401230701464858","article-title":"Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.","volume":"19","author":"Fava","year":"2007","journal-title":"Ann Clin Psychiatry"},{"issue":"12","key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4088\/JCP.v59n1204","article-title":"A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression.","volume":"59","author":"Landen","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4088\/JCP.v58n1005","article-title":"Pindolol augmentation of treatment-resistant depressed patients.","volume":"58","author":"Moreno","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4088\/JCP.v68n0712","article-title":"A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.","volume":"68","author":"Lin","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.","volume":"51","author":"Carpenter","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"1","key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004714-200302000-00005","article-title":"A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.","volume":"23","author":"DeBattista","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0447.2001.00148.x","article-title":"Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.","volume":"103","author":"Ferreri","year":"2001","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.","volume":"68","author":"Papakostas","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1586\/14737175.8.9.1299","article-title":"Olanzapine\/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility.","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-147-9-200711060-00003","article-title":"Risperidone for treatment-refractory major depressive disorder: a randomized trial.","volume":"147","author":"Mahmoud","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.","volume":"68","author":"Berman","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.","volume":"28","author":"Marcus","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1092852900020216","article-title":"Aripiprazole augmentation in major depression: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.","volume":"14","author":"Berman","year":"2009","journal-title":"CNS Spectrums"},{"issue":"1","key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00213-002-1147-6","article-title":"Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.","volume":"163","author":"Bech","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00406-007-0771-x","article-title":"Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder.","volume":"258","author":"Lecrubier","year":"2008","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"R28-14-20210128","first-page":"15","article-title":"Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.","volume":"40","author":"Robinson","year":"2007","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1185\/030079906X162809","article-title":"Quetiapine augmentation of treatment-resistant depression: a comparison with lithium.","volume":"23","author":"Doree","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"R32-14-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-3956(99)00011-4","article-title":"Concordance between self-report and clinician's assessment of depression.","volume":"33","author":"Corruble","year":"1999","journal-title":"J Psychiatr Res"},{"key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1192\/bjp.128.5.486","article-title":"A comparison between the Hamilton Rating Scale and the Beck Inventory in the measurement of depression.","volume":"128","author":"Bailey","year":"1976","journal-title":"Br J Psychiatry"},{"issue":"6","key":"R34-14-20210128","first-page":"246","article-title":"A comparison of self-reported versus clinician-related symptoms in depression.","volume":"48","author":"Rush","year":"1987","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000118423","article-title":"Comparison between clinician-rated and self-reported depressive symptoms in Italian psychiatric patients.","volume":"19","author":"Tondo","year":"1988","journal-title":"Neuropsychobiology"},{"issue":"4","key":"R36-14-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-0327(94)90101-5","article-title":"What factors predict discrepancies between self and observer ratings of depression?","volume":"31","author":"Domken","year":"1994","journal-title":"J Affect Disord"},{"issue":"2-3","key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(99)00055-5","article-title":"IDS-C and IDS-SR: psychometric properties in depressed in-patients.","volume":"56","author":"Corruble","year":"1999","journal-title":"J Affect Disord"},{"issue":"2","key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.npp.1300614","article-title":"Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.","volume":"30","author":"Rush","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1-3","key":"R39-14-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2006.03.024","article-title":"Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS.","volume":"95","author":"Carmody","year":"2006","journal-title":"J Affect Disord"},{"issue":"6","key":"R40-14-20210128","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1176\/ps.2006.57.6.829","article-title":"Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.","volume":"57","author":"Rush","year":"2006","journal-title":"Psychiatr Serv"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201006000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:15:37Z","timestamp":1618035337000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201006000-00014"}},"subtitle":["Clinician and Patient Self-Report Assessment of Improvement in Core Depressive Symptoms With Adjunctive Aripiprazole"],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181db320f","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}